After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 June 23, 2026 12:30 PM EDTCompany ParticipantsShaun Bagai - ...
Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation June 22, 2026 8:00 ...
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
The nutritional epidemiologists and other scholars who have led this push in public health are out to challenge an entire ...
Microsoft Threat Intelligence identified an active multi-stage intrusion campaign targeting hospitality organizations in ...
Perioperative anemia and red blood cell transfusions are important risk factors for morbidity and mortality in cardiac ...
A journal editor decided to retract and remove a bad study by an antivaxxer named Neil Z. Miller. RFK Jr. publicly demanded ...
Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results